Eloxx Pharmaceuticals, Inc. Quarterly Depreciation in USD from Q1 2017 to Q1 2023

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Eloxx Pharmaceuticals, Inc. quarterly/annual Depreciation history and growth rate from Q1 2017 to Q1 2023.
  • Eloxx Pharmaceuticals, Inc. Depreciation for the quarter ending March 31, 2023 was $15K, a 28.6% decline year-over-year.
  • Eloxx Pharmaceuticals, Inc. Depreciation for the twelve months ending March 31, 2023 was $71K, a 40.3% decline year-over-year.
  • Eloxx Pharmaceuticals, Inc. annual Depreciation for 2022 was $77K, a 32.5% decline from 2021.
  • Eloxx Pharmaceuticals, Inc. annual Depreciation for 2021 was $114K, a 67.6% increase from 2020.
  • Eloxx Pharmaceuticals, Inc. annual Depreciation for 2020 was $68K, a 21.8% decline from 2019.
Depreciation, Trailing 12 Months (USD)
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2023 $71K $15K -$6K -28.6% Jan 1, 2023 Mar 31, 2023 10-Q 2023-05-12
Q4 2022 $77K $11K -$17K -60.7% Oct 1, 2022 Dec 31, 2022 10-K 2023-03-31
Q3 2022 $94K $23K -$7K -23.3% Jul 1, 2022 Sep 30, 2022 10-Q 2022-11-10
Q2 2022 $101K $22K -$18K -45% Apr 1, 2022 Jun 30, 2022 10-Q 2022-08-12
Q1 2022 $119K $21K +$5K +31.3% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-12
Q4 2021 $114K $28K +$12K +75% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-31
Q3 2021 $102K $30K +$14K +87.5% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-10
Q2 2021 $88K $40K +$23K +135% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-12
Q1 2021 $65K $16K -$3K -15.8% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-06
Q4 2020 $68K $16K -$3K -15.8% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-30
Q3 2020 $71K $16K -$2K -11.1% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-08
Q2 2020 $73K $17K $0 0% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-16
Q1 2020 $73K $19K -$14K -42.4% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-07
Q4 2019 $87K $19K -$76K -80% Oct 1, 2019 Dec 31, 2019 10-K 2022-03-30
Q3 2019 $163K $18K -$57K -76% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-06
Q2 2019 $220K $17K -$8K -32% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-07
Q1 2019 $228K $33K +$12K +57.1% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-08
Q4 2018 $216K $95K +$80K +533% Oct 1, 2018 Dec 31, 2018 10-K 2021-03-12
Q3 2018 $136K $75K +$64K +582% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-06
Q2 2018 $72K $25K +$18K +257% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-07
Q1 2018 $54K $21K +$15K +250% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-09
Q4 2017 $39K $15K Oct 1, 2017 Dec 31, 2017 10-K 2020-03-06
Q3 2017 $11K Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-08
Q2 2017 $7K Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-10
Q1 2017 $6K Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-10
* An asterisk sign (*) next to the value indicates that the value is likely invalid.